SUVEN — Suven Life Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Suven Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	147	464	504	2,284	2,399
Net Total Accounts Receivable
Net Total Receivables	505	554	147	206	52.8
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	660	1,027	666	2,516	2,567
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	245	256	409	370	280
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,819	1,284	1,080	3,889	2,849
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	265	159	83.1	111	135
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	386	204	119	136	149
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,433	1,080	961	3,753	2,700
Total Liabilities & Shareholders' Equity	1,819	1,284	1,080	3,889	2,849
Total Common Shares Outstanding